H1 2026 Financial Communication Calendar
SOPHIA ANTIPOLIS, France, January 14, 2026–(BUSINESS WIRE)–Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announces today its H1 2026 financial communication calendar.
|
|
Publication |
Date |
|
|
|
FY 2025 results |
April 23, 2026, release after market close |
|
The Company will participate in upcoming investor events:
Allinvest Securities Biomed Forum
January 29, 2026 – Paris, France
Investor Access Conference
April 8-9, 2026– Paris, France
TP ICAP Midcap Annual Conference
May 6-7, 2026 – Paris, France
Portzamparc Mid & Small Caps Conference
June 24-25, 2026 – Paris, France
Please get in touch through the respective event booking systems, if you would like to request a meeting with Median management at these events. Events are for institutional investors only.
About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median’s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.
View source version on businesswire.com:
Contacts
MEDIAN TECHNOLOGIES
Emmanuelle Leygues
VP, Corporate Marketing & Financial Communications
+33 6 10 93 58 88
[email protected]
Investors – SEITOSEI ACTIFIN
Ghislaine Gasparetto
+33 6 85 36 76 81
[email protected]
Press – MAARC
Bruno Arabian
+33 6 87 88 47 26
[email protected]
Nicolas Entz
+33 6 33 67 31 54
[email protected]
link
